newsfilter
← Latest News
GlobeNewswire·

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2026 in Soleno Therapeutics, Inc. Lawsuit - SLNO

  • The Gross Law Firm issued a securities class action notice for Soleno Therapeutics, Inc. (NASDAQ: SLNO).
  • The class period is defined as March 26, 2025, to November 4, 2025.
  • Allegations state the company concealed safety concerns regarding its Phase 3 clinical trial for DCCR, specifically excess fluid retention in participants.
  • The complaint claims DCCR posed greater safety risks for treating hyperphagia in PWS patients than disclosed by executives.
  • Defendants are accused of hiding that DCCR had lower commercial viability & undisclosed risks including adverse regulatory action, patient discontinuation, & reputational fallout.
  • The deadline to register for the class action & seek lead plaintiff appointment is May 5, 2026.
  • Shareholders are encouraged to register via a provided link to enroll in portfolio monitoring software for case updates.
  • There is no cost or obligation to participate in the case.
  • The firm's office is located at 15 West 38th Street, 12th floor, New York, NY, 10018.